Your Health Story in One Place (with Travis Bond)

Most of us go to the doctor, get labs drawn, maybe even have a scan — and then never see the full picture of our own health. That’s changing.

In this episode of The Daily Apple, Kevin talks with Travis Bond, founder of Bio Insights, about the future of electronic medical records (EMRs) and why they’re not just for doctors. EMRs are becoming the backbone of how patients can actually see, understand, and act on their health information.

This isn’t a tech episode for physicians. It’s a conversation about how you can be more connected, informed, and in charge of your own health journey. From making sure your care team is on the same page, to finally having your results and history in one place, EMRs are making it possible to move from confusion to clarity.

In this episode:

• Why electronic medical records matter for patients, not just providers
• How EMRs make it easier to track your own progress over time
• The difference between “data overload” and “actionable information”
• How a more connected record leads to better conversations with your doctor
• What the future looks like when patients actually own their health story

It’s not about replacing your doctor. It’s about having the tools to understand what’s happening — and make decisions with confidence.

Prime Health Associates

Transcript

Kevin (00:01)
Hey everyone. Welcome back to the daily Apple. am, ⁓ I'm really kind of psyched about this conversation. I'm going to be talking to Travis bond MD, MBA. He's a, I just threw all the letters back on your name. I know how you love that. And then, who is the CEO of Bio Insights And we're going to talk about data, getting back into the hands of the, patient. And we're going to talk about why that's important.

talk about where he comes from. like we were just talking about off camera is you're definitely a different breed of cat for sure. And some work you've been doing with DC and kind of changing the way we look at all this stuff in the future. So it's really future driven. And I know when we met in Colorado, I was just after hearing your story, I was like, I've got to talk to this guy. I just want to be friends with him and see what he's up to. So, dude, thanks for making time. I appreciate it.

Travis Bond, MD, MBA (00:52)
Hey, thank you. Appreciate it.

Kevin (00:54)
Yeah. Well, I guess, I mean, we're going to be talking about Bio Insights. We're going to be talking about some cool stuff you just recently have been doing in Washington, DC with the government. And, and I want to get into that, but before we do that, I kind of want to get into your origin story. I mean, it's, it's kind of cool. It's different and, and it says a lot about you. So,

Travis Bond, MD, MBA (01:11)
Yeah.

Kevin (01:17)
You know, say more on that. Tell me about it.

Travis Bond, MD, MBA (01:19)
Yeah, I appreciate it. And I want to take several minutes to sort of unpack this because I think it is, central to the motivation, but I think it's also, a good story that really kneels home the point about the blind spots in Western eyes or allopathic medicine. So specifically on January the 18th, 2018, only three months after my wife's younger sister,

had passed away from metastatic cancer and had two teenage boys that we adopt. So we're already kind of in a sort of chaotic state. My wife calls me and says, everything's gonna be fine, we're okay. At work late in the afternoon, I'm like, what does that mean? And then she said, the house is on fire and the fire trucks are on their way, but we're outside standing by the mailbox like we always talked about if the house was on fire. So I'm like, wow, okay, was just three days ago, we buried your sister and adopted two kids and now we have seven and a lot going on.

Kevin (02:07)
Yeah.

Travis Bond, MD, MBA (02:14)
And so nine months we lived out of a suitcase and cardboard boxes and then we moved in. And then it's kind of like, okay, this is kind of getting up on the Christmas season again and life is back to normal. And about four weeks later, my wife was just climbing the stairs, we had a two story house, and she literally sat down at the top of the stairs and she could not breathe. mean, she looked as though maybe she had the flu or something because she was sweating and she was out of breath. I'm like, my goodness, what is wrong?

Another six months went by, Kevin. She went to, think it was 19 doctors, 26 visits and 13 procedures. And the final visit was Tampa General Hospital working her up for a double lung transplant. She's a 49 year old, know, natural mother of five plus two and otherwise healthy and completely had blindsided all of Western medicine as to what was going on.

And the only clue that we were given in all those providers was one old guy, a pulmonologist, you know, the one that probably started his career by going to people's homes, right? Before we had this sort of centralized, you come to me as a patient. And he kept asking this silly question, do you have birds at home? And we don't, by the way, and we have two dogs and they're hypoallergenic, right? So we're, know, we even dust regularly. I mean, we have a very clean home. And then I was working in New York at the time and

I was literally just sort of sitting overlooking the Hudson reading my Bible and literally the words popped in on my mind. you check the couch? And I'm like, hmm. So I text my wife and he said, Hey, just, you know, for whatever grins and giggles, go look at the tags on the couch. And she took a picture and what popped up was a hundred percent bird feathers. So the couch that she had been laying down to rest on

during the afternoon because she had no energy was literally putting her face into what is otherwise an environmental toxin. But all of these providers could not figure it out, right? So to me, that was a solid data point to say I was literally months away from my wife using somebody else's lungs. And if you know anything about five-year survival rate, it's it's single digits. So I mean, needless to say, I'm five years away from being a widow. And so it's pretty serious.

Kevin (04:14)
Yeah

Yeah.

Travis Bond, MD, MBA (04:24)
And so that was like, hmm, you know, so all these doctors that are highly educated, highly specialized were basically bested by a couch from Pottery Barn for lack of a better word, right? But one old guy, you know, had seen enough patients to recognize that sort of pattern. Then, yeah, it's called bird fancier's disease. And some people just have, it's not an allergy, it's a sensitivity to the natural sort of microbes that are on a bird's feather.

Kevin (04:40)
Was she just having a reaction to the birds or?

Travis Bond, MD, MBA (04:53)
Like we have little bacteria on our skin that sort of helps clean it off when it dies and so forth, right? So the birds have somewhat of a similar ⁓ parasite bacteria. So we got rid of the couches. Six months later, she was on steroids and so forth and she's better. But that sort of started.

Kevin (04:59)
Yeah.

And let me back up

for a second. It's important to know that even so a lung transplant is you and I know, or anybody listening or many people who are listening don't understand that, you know, a renal transplant is a different breed completely, but you talk about a lung transplant. That's a lot more, um, the outcome isn't as, as, as clear for that. So you're absolutely right. That's yeah.

Travis Bond, MD, MBA (05:34)
Yeah, I mean, it's very invasive. It's a very invasive,

right? I mean, similar to the kidney, all the blood in the body will go through the lungs, right? And so now you're talking about immune suppression, you're talking about post surgery infections and risk, right? And you're talking about, you know, immune suppression that can lead to a host of other things, right? And we're sort of, you know, literally just coming up, we didn't know it then to COVID. So you could have had somebody that would have been highly vulnerable to the COVID infection, respiratory, if she would have gotten COVID.

Kevin (05:40)
Yeah. Yeah.

Yeah.

Travis Bond, MD, MBA (06:02)
you know, seriously doubt she would have made it through. So I think that that's kind of part of my first sort of three strikes, if you will, that really kind of, I think, changed the sort of trajectory of my life. The second one was is that, you know, she's now more health conscious. So she sees functional medicine doctor sign near our neighborhood drives in, and she had suffered from PCOS and other things that are sort of hormone-based from her teenage years, right?

And so she's always had very horrible periods. last like 10 days. She would get very anemic. mean, know, things that really couldn't be treated. had endometriosis and every time, you know, she would give a live birth, she'd have bladder infections for a year afterwards. So just really kind of a lot of these underlying annoyances. Functional medicine doctor immediately said, yeah, you're estrogen dominant. You're this in terms of your gut and you're not getting enough of these hormones. Three months later, my wife is more healthy than she's ever been. So that's strike two.

It's like, okay, so again, she's been to, and I went to med school here in Tampa. I know a lot of doctors, we never had to wait for an appointment. We always kind of went in the back end of the schedule, right? So it's like, okay, that's two that they've missed. And then as I started to research, and I think this is most important, and actually this third strike was what really gave me the passion to create Bio Insights. It was, all those years of med school, we were always taught about...

Kevin (07:07)
Yeah.

Travis Bond, MD, MBA (07:20)
lab biomarkers as being part of the objective evidence we use to make a diagnosis. In these laboratories, we were told kind of just three things. They exist in three states, any biomarker, it's low, it's normal, or it's high. Fair enough, sounds reasonable. Really, there was no testing, if you will, or nothing that really sort of forced us as medical students in the time to look to know more about laboratories and their origin in terms of biomarkers. But functional medicine, that is sort of their cornerstone.

And when you understand that laboratory markers were created from population statistics, so basically they take 10, 100,000 people, and whatever that measurement is, 95 % of them are considered normal, and two standards, three standard deviations from the one on either side is 2.5%. That gives you your L and that gives you your H in terms of low and high. The problem is that it takes into account nothing about what is optimal.

Kevin (08:11)
Mm-hmm.

Travis Bond, MD, MBA (08:18)
It's kind of like going out and measuring the oil levels of 100,000 cars in Tampa, Florida and saying, okay, this is what we're going to say is the manufacturing specs. So the normal amount of oil there should be, that would be the most ludicrous statement anybody would make. Literally a user's manual tells you to the person who designed the engine on how much oil should be in there. It's not plus or minus, it is five quarts, five and a half or six, right? Well, the same thing is with a biomarker, there is an optimal range.

That then to me crystallized the fact that a lot of all of these sort of diagnoses, the things that really bothered me the most was in medicine where I think I sort of lost my zeal for it was when you get into your third year and you're especially in the hospitals.

you'll have these older doctors who will say, well, we used to use metformin for this, or we used to think this, or we used to think that. And the same part of my brain is like, well, what medical student were you yelling at 20 years ago for having something wrong? But now you probably should apologize. Meaning your point of reference in what was truth has now migrated to something else. So then you ask the question, well, what am I learning today? Is it now going to be 10 years from now or something that you're going to apologize for what you just said?

Kevin (09:25)
Yeah.

Travis Bond, MD, MBA (09:26)
So to me, to sum all of that up, it was a lot hides the normal for me, right? Meaning that providers have probably been misdiagnosing patients for a hundred years because if it's normal, that sort of data point from an objective marker is not even considered because it's normal. But in functional medicine, there's optimal, suboptimal and above optimal.

That's 95 % of population, right? And so when you were looking at all of these people, that would explain when they say, you know, I don't feel well or I just come off or, you know, I just, I'm tired or I have this brain fog. Functional medicine will glean that there is something going on underneath, right? There's smoke, there's fire. And that to me was then what technology are providers doing to know that.

And I was shocked that there wasn't a lot of platforms. There wasn't a lot of technology to help providers really understand that something out of normal is just as valid or something out of optimal is just as valid as something that was low or high.

Kevin (10:28)
And out of that birth, Bio Insights was kind of your idea. There was a niche that was not being met and, and it's really kind of a specific kind of thing. when did that idea kind of pop into your head and tell me about kind of the birth of where that came from.

Travis Bond, MD, MBA (10:45)
Yeah. So it was about three years ago as I was sort of thinking. So again, my background is when I left med school, but didn't, didn't complete my fourth year of residency. I literally went into technology and created the world's first browser based electronic medical record. And a few years later, sold that to All Scripts So I recognized that there was a gap in technology and healthcare. And I was, and I, I love technology, also loved healthcare. And I found a union, if you will, of those two

but in that space, I'm used to hundreds of competitors and whatever I was doing, whether it was Med device or whether it was EMRs and practice management, always had hundreds of competitors. When I looked in functional medicine, what I found was very different. Functional medicine is a lot of really passionate people who have great outcomes, but have a tendency to have a different sort of training trajectory. But more importantly, they're kind of like the Michelin chefs of the world.

they create their own cookbook of really great meals, and then that's a military secret, right? And so many of these successful functional medicine providers out there don't share their secrets. And I was thinking, well, what if I went back and partnered with the provider that saw my wife, that had been doing this for 17 years, and said, look, what if we created a clinical decision software that would look at symptoms, would recommend or give guidance on what labs you should order,

And then basically take that data together and programmatically using sort of predictive biostatistics, determine what is the probability of certain things going on from a cellular dysfunction perspective, right? Whether it's anemia, whether it's Candida's, whatever it may be. And she loved the idea. And so to me, that was like, wow, if we could somehow liberate a really great cookbook, but

understand that people don't have time to train for 10 years or for some multiple number of years, but if we could give them a piece of technology that would sort of be a co-pilot during whatever certifications or whatever sort of extra training that they're getting.

That has to be valuable. so as we said, literally then, is, is I think anybody on your show would be listening. I've come up with an idea. It sort of seems almost like apropos that you go then to, you know, one of the engines for buying domains is like, okay, what's the name of this and can I get the URL? And so I messed around with that for, for a few weeks, but it really occurred to me and I was shocked that I could buy this URL, but it really is. When you think about our company, our company really is about giving insights into biomarkers.

Kevin (13:10)
Yeah.

Travis Bond, MD, MBA (13:12)
And so therefore

I just flipped the two words and that's where Bio Insights comes from. And so was able to buy that. And then from my experience in the EMR worlds and passion about this clinical decision-making software, then I said, why don't we put sort of down the spine of the software as a workflow that will take in all these different inputs and give some guidance to somebody to really help what's going on. And then we'll wrap all the features and functions of an EMR around.

then I think we would have almost what I would call sort of a functional medicine operating system, right? We would have something that you could run your whole practice on, but now the process of seeing people would be predictive, predictable, reliable, and scalable. And so that then I think really became the four corners three years ago for BioInsights.

Kevin (13:58)
So you're talking about linking all this information to an EMR, which for listeners, electronic medical record, where we use everything to have all the patient's data in the traditional setting and have Bio Insights kind of linked in to docs that may want to use that as a different option for their patients, essentially. Is that what I'm understanding?

Travis Bond, MD, MBA (14:24)
Yeah, I think, I think you're exactly right. I think then the sort of the next sort of turn of the page of that is, like, what segment are we going after? mean, so who really, I mean, the world needs another EMR, like a, like a person with bad teeth needs another cavity, right? I mean, just, you don't need one, but, but functional medicine providers don't have a platform. They have, there's a couple of EMRs that are out there, I think have targeted this space, but I don't see that their functionality is different than your traditional sort of.

Kevin (14:36)
Yeah. Yeah.

Travis Bond, MD, MBA (14:53)
patient-centric design or I'm sorry documentation specific right and so EMRs were built really to streamline billing. I think functional medicine it's a cash pay basis so that's sort of a foregone conclusion so you're not really building something that's following sophisticated pay rules you're building something in functional medicine to say what is the root cause how do I actually cure what is going on in such a way that I return a person to health which is not really the end goal of westernized medicine.

Kevin (15:02)
Yeah.

Travis Bond, MD, MBA (15:23)
And by the way, for your users, I am not beating up on Westernized Medicine. think very much so there are millions of passionate people who want to heal. Unfortunately, it is the tools that they've been given and the training that they've been given that I think that has handicapped their efforts in actually finding true health and wellness. But just kind of going back then to the platform, I think that in functional medicine,

it is probably 10x more complicated than allopathic medicine because you're treating everything from the head down to the toes. And so there's a lot more data.

Kevin (15:52)
Yeah. And that's a good

point. want to, I want to double tap. we're not bashing traditional medicine. and I've said before, if I'm having severe chest pain, I know exactly where I want to go. And I know who I want to see. And I know their door to balloon times are great and all that kind of stuff. I mean, there's, I have nothing but respect for, for that whole thing, but that's a backend kind of a reactive.

approach that needs to be there but but yeah there's a definite space for this so that's why i'm so excited but carry on absolutely

Travis Bond, MD, MBA (16:22)
Yeah. And I would sort of underscore that in the fact that I want to market to and target providers who are disillusioned and frustrated. I want to bring those people that study to be gynecologists and cardiologists and gastroenterologists and all the other ologists that you can think of and to say, look, here is a tool that will replace your EMR if you want to practice a functional medicine type of visit. And if you do that, then we have

Kevin (16:38)
Yeah.

Travis Bond, MD, MBA (16:51)
millions of lines of code that has been created to literally look for hundreds of things at any given time and come up with a probability scientifically that that stuff exists and then give you a pharmacy where you now have the ability to send compounded medications where you have the opportunity for us to pill pouch things that create adherence. And so kind of having a full system to where you feel like

you know, I think these are these mountains in front of these allopathic providers. It's like, wow, I got to think about supplements. I got to think about where I get them. I got to think about all these other things.

Well, I wanted to have one solution that was customizable to allow for their ongoing education or what they have known in the past to now be operationalized and software now. So yeah, I think we both share a love for our providers who are out there. think that just now, and I think this is a great sort of time to sort of segue into the government. I think we are now following, we're in a period of time where, you know, all of these sort of dissatisfactions with an allopathic or Western approach.

Kevin (17:40)
Mm.

Travis Bond, MD, MBA (17:55)
is now sort of seeing more policy, that we are thinking about health. I we're legitimately thinking about health and what does that mean? And so, know, first order of business, we must get rid of these dyes that are.

are toxic in their food supply, right? And he sort of had this order of operations and then he's gone after vaccines to say, hey, we should test these things before we put 72 of them in our children. And so I have, you know, I've been in DC many times throughout my career and we were lucky to sort of make a case for functional medicine, but many people are already up there, but I think we're the only vendor that actually had the case like, you know, maybe HHS, CMS.

For your listeners, those are all three letter acronyms that basically control the checkbooks on what the healthcare is paid for by the government. They should be giving functional medicine, root cause medicine, a seat at the table. You know, and two weeks ago they finally did.

Kevin (18:38)
Right.

Wow. Yeah. Tell us about, speak more about that. really wanted to dig in when I talked to you about that. just didn't have time, but, yeah, tell me about that experience. What, how did that go?

Travis Bond, MD, MBA (18:58)
You know, it was really great. so, you know, the actual journey sort of began or, you know, what led up to a couple of weeks ago, began a couple of months before then. And so you really have for the first time in, in, in history, it's been recalled, right? That you have the head of HHS is aligned with CMS and is aligned with Medicare. And now you have this sort of digital service that runs out right out of the White House. That's

that its sole purpose is to modernize government with new technologies, they're literally all singing off the same page, right? So one is, is that there's a massive amount of fraud, waste and abuse. And so obviously Doge was that sort of the center cornerstone of saying, where's a lot of that going on? But in healthcare, we have, you know, over a $3 trillion budget here in the U.S. that the government writes checks for every year.

And unfortunately, some are saying up to 30 % of that is fraud, waste or abuse. So we'll get rid of fraud and we'll get rid of abuse. So let's just talk about waste. And so where would waste come from? And so let's just say that's a third of the thirds. We're talking hundreds and hundreds of billions of dollars is that if the Kevins in the world or my wife in this instance went from one provider to the next provider, provider B does not have the records of provider A.

So provider B in their sort of decision-making algorithm needs to think, well, I need this test, you know, I might need to do this procedure. And so if you do not have sort of the cumulative, you know, decision-making and other assets that other providers sort of aggregated, you're forced to sort of go through this learning curve each time. And so that costs the government literally trillions of dollars. And so it was decided when Oz came in to head up CMS, he was obviously very passionate about help.

he had tapped to work with the USDS and DOGE to say, okay, what is it that we can do to sit there and align technology such that we do not see all these providers in the dark and most importantly, we don't see the patients equally in the dark. And so what they decided is they picked 60 companies. They invited us all to the White House to basically say, we're going to make health technology great again or health tech.

Kevin (21:06)
Yeah.

Travis Bond, MD, MBA (21:06)
And

we were really excited. And so they picked several categories to which they felt were strategic. So one was the interoperability between these HIEs, which are basically just big data houses that sort of aggregate data and tap into that. Then they picked apps and a few others. And so there's one category that they thought we were uniquely aligned with in functional medicine. was, is that basically diabetes costs the government about a trillion dollars a year.

Kevin (21:31)
Sure.

Travis Bond, MD, MBA (21:31)
in the US, right? So that's with a T. So we've gone past the B's and you know, and that's a massive amount of money. And so it was, what can we do to help take records, which by the way, this Make Health Tech Great Again is all about each person within the next 12 months, especially starting with Medicare beneficiaries, will have all of the records on their phone. So they will now be the conduit between these providers.

Kevin (21:40)
Hmm.

Travis Bond, MD, MBA (22:00)
and their EMRs to say, yes, I have all my medical records for me here, scan this code, and you as the vendor will be able, you will be required to now interact with the government and the health exchanges to pull that data into your EMR. So no more redoing tests. So Dr. B is now just as informed as Dr. A, and so we'll see, right?

Kevin (22:19)
Will this go, as we know, there are a handful of different EMRs, epic to name one. There's a few that are more common. This will go between EMRs and be able to, without hassle or that.

Travis Bond, MD, MBA (22:34)
Yeah, I mean, kind

of think of it as a digital wallet, right? A digital wallet that contains all your medical records and everybody else is supposed to accept the wallet, which I think is probably the best analogy. But there was one, but they wanted one side of these vendors to basically be curative. Basically they said, look, we want you to be involved in not just part of the ecosystem that sort of the infrastructure, like a power company that sort of carries electricity across the nation, but we want.

Kevin (22:41)
Right, got it. Gotcha.

Travis Bond, MD, MBA (23:01)
some of you to really look at some of the diseases that are really costing the government a lot of money. And by obviously association, it's not particularly pleasant for the person to have the disease. So we were picked specifically about what functional medicine can do for diabetes prevention and treatment, of which functional medicine we deal with that every day, right? And so, especially if it's non-insulin dependent, that can be reversed with a high degree of confidence.

Kevin (23:17)
Mm-hmm.

Travis Bond, MD, MBA (23:28)
and having somebody who is taking metformin and all the other conditions with pre-diabetic and diabetic, all the organ damage that happens because of that. You're talking about really turning around the quality of life for potentially tens of millions of people, if not more. So yeah.

Kevin (23:44)
Yeah. And that feeds into

all the other disease processes. And I can't tell you the number of times that, you know, you're in the ER and you know, there's somebody who comes in and feels bad and they're peeing all night and lightheaded and they've got blood sugar of like 300 or, you know, or whatever. they, and you ask them, did you know this? And it's like, well, last time I saw my doctor, my sugar was high. They just told me to watch it. And that's all the data and information they had and no fault to the care, it was just the way it's set up. You just don't have enough time to sit down.

Travis Bond, MD, MBA (23:59)
Mm-hmm.

Kevin (24:12)
with people to kind of make those changes. yeah, go on. Yeah.

Travis Bond, MD, MBA (24:18)
Yeah.

So yeah, I think we're excited about that, obviously, and feel honored to be the only functional medicine company at that table. Right. So one of 60 and, we're sort of raising our little functional group cause medicine flag. But I think that, you know, it is Oz and Kennedy, you know, who have been on this functional medicine track personally themselves for decades is now trying to get that into the government. So clearly that excites us, you know, and I'm looking forward to over the next 12 months.

Kevin (24:25)
Yeah.

Travis Bond, MD, MBA (24:45)
of building out our infrastructure to accept these digital wallets, which will have these records, but we're going to take what's in that chart and we're going to give people personalized care plans from a root cause perspective, right? Okay, you have insulin insensitivity. How do we get rid of that? What's going on? What are the likely things that you can do? And so I'm very, very excited about our opportunity to sort of really treat, you know, tens of millions, if not more Americans, not to mention this clearly, you know, globalizing this is not, is not a

or big uplift either.

Kevin (25:15)
Mm hmm. Yeah. It's just, it's so you're taking all the medical records, you have it in a digital wallet, but also have a personalized care plan for that the patient has access to easy access to granite and they can share that with their provider as well. And as another, you know, adjunct to their care, essentially, that's

Travis Bond, MD, MBA (25:36)
Well, that's

what our software already does. So it's not a big lift, right? So if we already know that we know your labs and we know your symptoms, we already have the predictive statistics in the software. And so if you specifically have been diagnosed as diabetic or pre-diabetic, the system is going to give you a personalized care plan. That's what our system already does, but it also does it for 300 more things, right? And so to really just really carving off one of our protocols and basically giving a direct to patient access to that is not a big lift for us, but it certainly is, I think,

the potential to truly be just magnificent. And so some of the other companies, Noon was selected as well, right? And so even Albertsons, mean, so I think the government is doing a great job to try to look at the landscape of who can be agile, but legitimately stand up something in 12 months, not 12 years. But I love this fact that we're actually going to get records

onto a person's phone versus I think right now one of the sort of death holds, especially when you think about it and everybody I'm sure all your users know. So if you're being seen by a large hospital system and they say, oh, I'm going to refer you for a colonoscopy, they're always going to say, well, I'm going to refer you to someone across the street because he has your medical or she has all your medical records because we're using the same system. Right. So this has been, I think, a very effective selling strategy for Epic and others that it says, look, you know,

as you branch out from the hospital to the ambulatory environment, you now sort of have a captive audience because you say, you don't want to go through that clipboard experience again with some other doctor, right? And so it really is sort of a soft leash, if you will, ⁓ in that I think the government really says, you know, this doesn't really sound like true capitalism, you know, and for those of your listeners who remember something called Aura.

Kevin (27:13)
Yeah.

Travis Bond, MD, MBA (27:21)
I mean, the government to their credit, you know, back in 2008, '09, '10 paid $35 billion for every doctor to get a medical record, including the hospital. So I do think that they certainly had hopes that it was going to be interoperable between all of these installs.

Kevin (27:32)
Yeah.

I remember that time whenever we had forced changeover and anybody who was in their 40s, early 40s at that time got reading glasses. I mean, it just kind of popped over because there's all this time right on the screen instead of just writing on the chart. Yeah, I remember that. 35 billion, wow. I didn't know they spent that much on that. That makes sense. Dude, I'm excited about this. You're talking about changing

the way healthcare works are really empowering patients and physicians. you know, I can't tell you the number of times I've talked to doctors wanting to even get into this space. They don't know where to begin and what do I learn? and this kind of puts some data into the hands of the right people at the right time. So it's yeah, phenomenal. Yeah, you're doing cool.

Travis Bond, MD, MBA (28:25)
I think so

in kind of going back to my three strikes, right? I mean, our software would pick up a bad couch, you know, and our software, you know, understands different labs and understands hormones. So I do think that there are perhaps millions of providers around the globe. It's like, you know, I trained under this one sort of discipline. where's the sherpa to get me to the other mountain. I certainly hope that we continue to do a great job in understanding that market and how to sort of equip people, not to pull them out and make them go to

school again, but how can we contemporaneously take our technology? It also has embedded applet education, but as they now go back and say, take a course in bio-identical hormones or take a case and gut microbiology and so forth, I think that we have a good start. I think we have a great mission. And I think there are a lot of providers who say, I didn't really go, so to give up my entire youth to go to undergrad.

know, med school, residency, probably on their second or third marriage. I mean, they, you these people have sacrificed quite a bit, only to really being left with kind of, if you ever thought about it, did the point in care for allopathic medicine, only four things can ever happen. And you mentioned one of them, by the way. One is, I'll give you a pill. Two is, I'll refer you to somebody. Three, I'll do a procedure or a diagnostic.

Kevin (29:37)
Yeah.

Travis Bond, MD, MBA (29:42)
And the fourth one you've mentioned, let's wait and see. Literally there's only four tools in their tool belt. And so you have to sort of kind of almost be empathetic to this, you know, for everyone involved in that exam room, because there really isn't a lot in a traumatic, right? So if you and I get hit by a car, I don't want supplements and I don't want to know my genomics. I really want to go straight to the ER. But all this other stuff that is creating sort of just really miserable health outcomes, I think functional medicine is something I'm so passionate about that I went

Kevin (30:03)
Sure.

Travis Bond, MD, MBA (30:12)
back last year and finished my fourth year of med school.

Kevin (30:16)
That's, want to double tap on that. I just, I love that about your story. It's like, I'll

go back and finish a fourth year. How was that?

Travis Bond, MD, MBA (30:25)
Yeah,

well, I wasn't of traditional age, right? And so it's like, okay, who's the old guy in the room? But, you know, but it was, you know, I did find a school that accept three years, and my transcripts and, you know, passing the US on the lane and all that. And so I was able to find a program that was, you know, flexible for me, but it was, I think it really recognized the fact that I've been disenfranchised. Many years ago, I was re integrated.

and so much that I would do a startup and a fourth year of med school all at the same time.

Kevin (30:56)
Yeah. Yeah. Well, cool. just such a cool story. And I love the innovation and I just think this is, I mean, you're getting data in the right hands. I'm totally jazzed about this. And, and, you know, a lot of physicians, the whole functional medicine kind of thing is kind of a secret, you know, you don't really talk about it, but what do I need to know about it? How can I help my patients? and I've met people,

utilizing some of this in their practices or trying to incorporate it because they want what's best for their patients. Right? So what you're doing is, and you're empowering the average physician who's given up, like you alluded to, their whole twenties are gone because you spend all your time in that. And then you got to work fast because you got to be in this insurance based model. You got to make patients happy. You know, you have to.

There's a lot of markers to make, you know, to make yourself a successful, good physician. But, ⁓ but I think this will be an awesome tool, but ⁓ I think you're really changing things. And the fact that you have the ear of the White House and, ⁓ and that's super cool. You're doing cool stuff. This is great, Travis. I'm excited to see where this goes for sure.

Travis Bond, MD, MBA (32:04)
Well thank you very much. We're blessed and we're going to be good stewards of this opportunity and can't wait to team up with providers and find ways to help to prostrate them and to start to heal.

Kevin (32:16)
Yeah, well, are there any thoughts you want to leave us with or anything else?

Travis Bond, MD, MBA (32:21)
Well,

I do. There's a couple things. One, just want to say, and this sounds almost perhaps a little harsh, but I think passive patients in Western medicine have a good chance of becoming dead patients, right? Meaning that the longer that you're in the system, the more fragmented, confusing everyone is. And now the third leading cause of death in the United States are providers. And so we need to recognize the fact that as with my wife,

⁓ I would be literally a widow now had we been passive. Had we sort of just hopped on the conveyor belt and allowed the system to sort of take us where it may, kind of like bags in an airport, you know, we would have had a really bad outcome. And so I would just say that for everyone, regardless of profession, you all of us will be a patient at some point. I think if you're not engaged, you probably, may not have the best outcome if you sort of leave it up to people and just assume the system's

Kevin (32:57)
Hmm.

Travis Bond, MD, MBA (33:14)
taking care of you. If things would have happened any differently, I'd be widowed and those two blue couches from Pottery Barn would still be there. We would never know, right?

Kevin (33:22)
Yeah, you know, you're absolutely right. Passive patients really become dead patients. That is kind of harsh, but it's true. You know, we're not passive about our cars. We're not passive about our finances. The only thing we're traditionally in the history is that we've been passive about is our health. You know, if I'm sick, I'll go to the doctor. If I'm, this, I'll do that. But

and I think that's changing for sure. And then the fact that we are going to be giving them tools to help them not be passive. Cause a lot of times, you know, patients don't know where to start. if they're not educated on it. So yeah, this will be, this will be very cool to give them kind of a launching pad to not. Yeah.

Travis Bond, MD, MBA (34:01)
Can't wait.

Can't

wait. And then we're going to tell their providers what's wrong with them and how to make them better. And we'll even probably give them a lookup tool to find functional medicine providers in what we would call geocoding in their, area. So we look forward to this. I think it's going to be great. have great optimism and expectation to see that vendors are being encouraged to break down these sort of data silos. And I'm really encouraged that now we have tools like AI and other systems out there that say, Hmm, there's a way to.

treat this.

Kevin (34:31)
Yeah.

So Travis, how do people find you and obviously Bio Insights? How do people find out more? What's the best way to go about that?

Travis Bond, MD, MBA (34:40)
Yeah,

I think first off our website of course, you so that's Bio Insights with an s.com There's a link on there to book a demonstration or a call

Kevin (34:50)
Yeah.

Travis Bond, MD, MBA (34:50)
⁓

as well as information about what we do. Certainly people can email me directly. It's just my first name, travis, T-R-A-V-I-S, at bioinsights.com. And I look forward to just any inquiries, but I also, anybody that just wants to shoot me an email and say, hey, have you thought about this or so forth, I think we're in a very sort of humble posture where we know that we're just three-year-olds in functional medicine and we have a lot to learn, but that we really want input from other people and certainly open for any kind of collaborations that makes

sense and sort of pass the straight face test as I always say. But ultimately I would love to sort of see five years from now and people say, yeah, functional medicine runs on Bio Insights.

Kevin (35:27)
Yeah, well cool. Well Travis, thank you for your time. I look forward to staying in touch and I know I'll be seeing you next month. So I'm excited for the next steps for you guys. anyway, thanks so much. I appreciate you being here.

Travis Bond, MD, MBA (35:43)
Thank you so much. know, have a great day, Kevin. Okay.

Kevin (35:46)
All right, see you guys later. Thanks everyone for listening and we'll see you guys next time.